Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 51 clinical trials
Featured trial
SAR408701 Versus Docetaxel in Previously Treated, Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Positive Metastatic Non-squamous Non-small-cell Lung Cancer Patients (CARMEN-LC03)  

Primary Objectives: Study is designed with two primary endpoints that will be analyzed on randomized participants at the time of the cut-off date for each given analysis (progression free survival [PFS] and overall survival [OS]) Study success is defined either on PFS or OS The primary objective is to determine …

  • 180 views
  • 06 Feb, 2023
  • 5 locations
Featured trial
Weekly Basal Insulin - Allowing More Flexibility With Treating Type 1 Diabetes. (In the Greater Seattle Area.)

We are currently seeking volunteers who are diagnosed with Type 1 Diabetes and who are treating with multiple daily injections (basal and bolus insulin regimens) for the past 1 year.This is a study of an investigational once weekly basal insulin. Participants will be assigned to one of two groups: half …

Accepts healthy volunteers
insulin
sugars
hemoglobin a1c
  • 36 views
  • 08 Oct, 2021
  • 1 location
Phase 2 Trial of Encorafenib Plus Binimetinib for Patients With BRAF V600 Mutated Relapsed/Refractory HCL

MRI scan: Participants will lie in a machine that takes pictures of the body. They may have a contrast agent injected into a vein. Eye exam Participants will take the study drugs by

  • 0 views
  • 27 Oct, 2022
  • 1 location
  • 1 views
  • 22 Oct, 2022
  • 1 location
Phase 2 Trial for Binimetinib for Patients With Relapsed/Refractory BRAF Wild Type Hairy Cell Leukemia and Variant

with: Medical history Physical exam Blood and urine tests Lung and heart tests Eye exam Bone marrow biopsy: A needle will be injected

  • 6 views
  • 25 Oct, 2022
  • 1 location
Village-Integrated Eye Worker Trial II (VIEW II)

The vast majority of blindness is avoidable. The World Health Organization (WHO) estimates that 80% of cases of visual impairment could be prevented or reversed with early diagnosis and treatment. The leading causes of visual impairment are cataract and refractive error, followed by glaucoma, age-related macular degeneration (AMD), and diabetic …

glaucoma
retinopathy
cataract
diabetic retinopathy
macular degeneration
  • 42 views
  • 10 Feb, 2022
  • 1 location
Effects of a Patient Portal Intervention to Address Diabetes Care Gaps

The purpose of this study is to evaluate the effect of a novel patient portal intervention on the number of patients with diabetes care gaps (e.g., no diabetes eye exam i the last 12 months

  • 0 views
  • 13 May, 2022
  • 1 location
An Investigation of Vitamin A Palmitate Supplementation in Patients With Age-Related Macular Degeneration (and Without Reticular Pseudodrusen) and Delayed Dark Adaptation

and older with AMD and normal liver function Design Participants will be screened with: Medical and eye disease history Eye exam: The pupil will be

tubal ligation
vitamin
eye drops
be 50
reticular pseudodrusen
  • 115 views
  • 20 Oct, 2022
  • 1 location
Vitamin A Palmitate Supplementation in Patients With Reticular Pseudodrusen (RPD) and Delayed Dark Adaptation

> Medical and eye disease history Eye exam: The pupil will be dilated with eye drops. Pictures will be taken of the retina and the inside of the eye. Including the screening visit

reticular pseudodrusen
eye exam
  • 28 views
  • 07 Oct, 2022
  • 1 location
Phase II Study of Combination of Trametinib (MEK Inhibitor) and Hydroxychloroquine (HCQ) (Autophagy Inhibitor) in Patients With KRAS Mutation Refractory Bile Tract Carcinoma (BTC).

activities will be assessed. They will have blood and urine tests. They will give a tumor sample. They will have heart tests. They may talk with a heart doctor. They may have an eye exam. They may have a

EGFR
KRAS
hydroxychloroquine
cancer
measurable disease
  • 0 views
  • 24 Oct, 2022
  • 1 location